Este trabalho mostra a síntese, em bons rendimentos (57-95%), de duas séries de 1-alquil(aril) amino-2-oxo-5-(2-oxo-3,3,3-trialopropiliden)-pirrolidinas 5 e 6, a partir dos intermediários 4-[alquil(aril)amino]-6-oxo-7,7,7-trialo-4-hepteno-atos de metila 3 e 4 obtidos por substituição da metoxila-nos precursores 4-metoxi-6-oxo-7,7,7-trialo-4-heptenoatos de metila 1 e 2, pela série de aminas primárias RNH 2 , onde R = PhCH 2 , PhCH 2 CH 2 , Ph, 4-MeC 6 H 4 , 4-MeOC 6 H 4 , 4-ClC 6 H 4 , 4-BrC 6 H 4 , 2-piridnil, 5-metil-3-isoxazolil, 4-NH 2 C 6 H 4 . A estrutura molecular dos produtos inéditos foi atribuída a partir dos dados de RMN 1 H, 13 C e espectrometria de massas. A configuração geométrica dos compostos 3d e 5b foi confirmada pelos dados de difração de raios-X em monocristal.
Introduction
We have systematically used the acetals acylation method for synthesis of wide range of 4-alkoxy-1,1,1-trihalo-3-alken-2-ones. These 1,3-dielectrophilic precursors have proved to be important building blocks for regiospecific synthesis of heterocyclic compounds bearing trihalomethyl group 2,3 with important pharmacological 4, 5 and synthetic applications. 6 The levulinic acid (4-oxopentanoic acid) is an important fine organic material from renewable source, with acetyl group attractive for us. 7 Our continuing interest in 1,3-dielectrophilic compounds has led us to study a new aspect of the application of the acetal acylation method for producing methyl 4-methoxy-6-oxo-7,7,7-trihalo-4-heptenoates 1 and 2. 8 On the other hand, the pyrrolidin-2-ones, have received considerable attention due to their activity in CNS as nootropic drugs. Piracetam-like nootropics revert amnesia induced by scopolamine and other amnesing drugs, electroconvulsive shock and hypoxia with an unknown mechanism. 9 In general, they show no affinity for the most important central receptors, but are able to modulate the action of these most important central neurotransmitters, in particular acetylcholine and glutamate. Extensive study of the modes of action of the 2-pyrrolidinones has revealed various pharmacological effects, with striking differences between drugs. Continuing with our systematic studies on synthesis and application of 4-alkoxy-1,1,1-trihalo-3-alken-2-ones we report an efficient approach for synthesis of a series of 1-[alkyl(aryl)]-5-(3,3,3-trihalo-2-oxopropylidene)pyrrolidin-2-nes from 1 and 2. This study deals with formation of the methyl 4-alkyl[aryl]amino-6-oxo-7,7,7-trihalo-4-heptenoates 3 and 4, and their intramolecular cyclisations to new 1-alkyl[aryl]-5-(3,3,3-trihalo-2-oxopropylidene) pyrrolidin-2-ones 5 and 6.
Results and Discussion
The precursors methyl 4-methoxy-6-oxo-7,7,7-trihalo-4-heptenoates 1 and 2 were obtained by acetal acylation method as described previously. 8 The fluorinated enaminones 3 were synthesized and isolated by reaction of the methyl 4-methoxy-6-oxo-7,7,7-trifluoro-4-heptenoate (1) with primary alkyl [aryl] amines in CH 3 CN at variable temperatures depending on used amine. The analytical data have demonstrated the formation of the methyl 4-alkyl[aryl]amino-6-oxo-7,7,7-trifluoro-4-heptenoates 3,b-k (Table 1 , Supplementary Information), with (Z)-4-alkyl[aryl]amino-1,1,1-trifluoro-3-alken-2-one moiety. 2 Primary alkylamines (b, c) reacted readily with 4-methoxy-1,1,1-trifluoro-3-alken-2-ones in MeOH, EtOH or i-PrOH by displacement of -methoxy substituent, in these cases, the intramolecular cyclocondensation of the resulting methyl 4-alkylamino-6-oxo-7,7,7-trifluoro-4-heptenoates 3,b,c to pyrrolidin-2-ones also took place, affording mixtures of products 3 and 5 at room temperature. However, when the least reactive primary arylamines were employed, and the reaction was carried out in MeOH or EtOH at room temperature, unreacted 1 or mixtures of methyl 4-ethoxy-6-oxo-7,7,7-trifluoro-4-heptenoate and 1 were recovered. The methyl 4-arylamino-6-oxo-7,7,7-trifluoro-4-heptenoates 3,d-j were obtained in refluxing MeCN or at room temperature, by addition of equimolar amount of Et 3 N or lutidine (Table 1 , Supplementary Information). Reaction of the methyl 4-methoxy-6-oxo-7,7,7-trifluoro-4-heptenoate 1 with 1,4-diaminobenzene in a stoichiometric ratio 1:1 or in 2:1 mol-equiv ratio in MeCN at room temperature lead to the methyl 4-(4-aminophenylamino)-6-oxo-7,7,7-trifluoro-4-heptenoate 3k, but under reflux conditions the intramolecular cyclisation took place under formation of only 1,1'-(1,4-phenylene)-bis(5-(3,3,3-trifluoro-2-oxopropylidene)-2-pyrrolidin-2-one) 5k (Scheme 1).
The structures of fluorinated enaminones 3 were confirmed by elemental analysis, mass spectrometry and 1 H, 13 C NMR spectral data. Compounds 3d and 5b were subjected to single crystal X-ray analysis (Tables 4 and 5 ). This measurement has showed in solid state the molecular structure with Z-configuration on alkene moiety and intramolecular hydrogen bond O3---H1-N1 for methyl 6-oxo-4-phenylamino-7,7,7-trifluoro-4-heptenoate (3d) (Figure 2 ). X-ray diffraction analysis performed on 1-benzyl-5-(3,3,3-trifluoro-2-oxopropylidene)pyrrolidin-2-one (5b) showed the E-configuration for enaminoketone moiety (Figure 3) , confirming that the intramolecular cyclisation occurred with the inversion of configuration. In both structures the trifluoromethyl group suffers a rotational disorder and was refined as two components as approximately 60%/40% occupancy (Tables 1 and 2 ).
The methyl 4-methoxy-6-oxo-7,7,7-trichloro-4-heptenoate demonstrated high reactivity for nucleophilic attack of alkylamines at -carbon of the vinyl group, taking place of methoxy group, followed by fast intramolecular cyclisation to 1-alkyl-5-(3,3,3-trichloro-2-oxopropylidene)-pyrrolidin-2-ones. With the intention to isolate of the methyl 4-alkylamino-6-oxo-7,7,7-trichloro-4-heptenoates 4,a,c, the heptanoate precursor 2 was reacted with primary alkylamines in dichloromethane or chloroform at -5 -0 ºC for 2 hours. Primary arylamines were reacted in MeCN at room temperature (Scheme 1) for 6 hours, and 4-arylamino-6-oxo-7,7,7-trichloro-4-heptenoates 4,d-j were isolated in good yields and in high purity (Table 2 , Supplementary Information). Reactions in EtOH or i-PrOH gave poor yields with complex mixtures of unidentified products, maybe involving transesterication and/or chloroform elimination.
The molecular structures of methyl 4-alkyl[aryl]amino-6-oxo-7,7,7-trichloro-4-heptenoates 4,a,c-j were confirmed by elemental analysis, mass spectrometry and 1 H, 13 C NMR spectral data. The 1 H NMR spectra showed characteristic broad signals for N-H between 13.4-13.8 ppm, the vinylic hydrogen at 5.85-5.89 ppm and for methoxy group as intense singlet at 3.60-3.67 ppm.
12,13 The 13 C NMR spectra showed the signals of methoxy group at characteristic region 51.9-52.9 ppm, for the carboxylic ester carbon at 181.2-181.7 ppm and low intense signal at 96-99.1 for trichloromethyl carbon confirming the attributed structure for methyl 4-alkyl[aryl]amino-6-oxo-7,7,7-trichloro-4-heptenoates 4,a,c-j.
The intramolecular cyclisation of isolated methyl 4-alkyl[aryl]amino-6-oxo-7,7,7-trichloro-4-heptenoates 4,a,c to 5-(3,3,3-trichloro-2-oxopropylidene)pyrrolidin-2-ones 6,a,c occurred in MeCN, affording quantitative yields without Et 3 N addition. The products 6,d-f and 6h were obtained in good yields by stirring of 4 in MeCN at variable temperatures for 2 to 6 h. In general, the products 6 can be readily obtained in excellent yields without isolation of enaminones intermediates, by the reaction of precursor 2 and appropriate amine in MeCN under reflux [chloro]-4-methoxy-6-oxo-4-heptenoates 1 and 2 were prepared according to reference 8. All melting points were determined on a Reichert Thermovar instrument and are uncorrected. , using TMS as internal standard. Mass spectra were registered with a HP 6890 GC connected to a HP 5973 MSD and interfaced by a Pentium PC. The GC was equipped with a capillary column (30 m, 0.32 mm of internal diameter), and helium was used as the carrier gas. The elemental analyses were performed on a Perkin-Elmer 2400 CHN elemental analyser (São Paulo University/Brazil).
Methyl 4-alkylamino-6-oxo-7,7,7-trifluoro-4-heptenoates (3b and 3c)
To a stirred solution of methyl 7,7,7-trifluoro-4-methoxy-6-oxo-3-heptenoate 1 (5 mmol, 1.28 g) in MeCN (5 mL), kept at 25 ºC, was added benzylamine (5.1 mmol, 0.56 mL) or phenethylamine (5.1 mmol, 0.62 mL) in MeCN (5 mL). The mixture was stirred for 6 h. The solvent was evaporated and the solid residue was dried under vacuum. The enaminones 3b and 3c were purified on silica-gel chromatographic column using chloroform-hexane (2:1) as eluent, yield refers to purified product. The synthesis of 5-(3,3,3-trifluoro-2-oxopropylidene) pyrrolidin-2-ones from methyl 7,7,7-trihalo-4-methoxy-6-oxo-4-heptenoates and primary amines can be characterised as an Paal-Knorr process for pyrrole heterocyclic from [CCCC + N] building blocks. Mechanistically, it is conceivable that the reaction involves an initial attack from amines to -position, leading to enaminoketone moiety, 14 then an imino intermediate as shown in Scheme 3, which allow the rotation of trihalocarbonyl group around C4-C5 bond on 4-amino-6-oxo-7,7,7-trihalo-4-heptenoates, and intramolecular nucleophilic attack of imino nitrogen to ester carbonyl lead to pyrrolidin-2-ones. 
Experimental

Methyl 4-arylamino-6-oxo-7,7,7-trifluoro-4-heptenoates (3,d-k)
To a stirred solution of methyl 7,7,7-trifluoro-4-methoxy-6-oxo-3-heptenoate 1 (5 mmol, 1.28 g) in MeCN (5 mL), was added the appropriate arylamine (Aldrich, 5.1 mmol) in MeCN (5 mL). The mixture was refluxed for 6 to 24 h. Then the solvent was evaporated and solid residue was dried under vacuum. Enaminones 3,d-k were recrystallised from hexane-chloroform (2:1), yield refers to purified product. 
Methyl 7,7,7-trichloro-4-alkylamino-6-oxo-4-heptenoates (4a and 4c)
To a stirred solution of methyl 7,7,7-trichloro-4-methoxy-6-oxo-3-heptenoate 2 (5 mmol, 1.52 g) in CHCl 3 (5 mL), kept at 25 ºC, was added n-propylamine (Aldrich, 18570-1, 5.1 mmol, 0.42 mL) or phenethylamine (Aldrich, 24095-8, 5.1 mmol, 0.62 mL) in CHCl 3 (5 mL). The mixture was stirred for 2 h. Then the solvent was evaporated and solid residue was dried under vacuum. The enaminones 4a and 4c were purified on silica-gel chromatographic column using chloroform-hexane (2:1) as eluent, yield refers to purified product. 
Methyl 7,7,7-trichloro-4-arylamino-6-oxo-4-heptenoates (4d-4i)
To a stirred solution of methyl 7,7,7-trichloro-4-methoxy-6-oxo-3-heptenoate 2 (5 mmol, 1.52 g) in MeCN (5 mL), kept at 25 ºC, was added appropriate arylamine (Aldrich, 5.1 mmol) in MeCN (5 mL). The mixture was refluxed for 2 to 6 h. The solvent was evaporated and the solid residue was dried under reduced pressure. The enaminones 4d-i, 4k were recrystallised from hexane: CHCl 3 (2:1), yield refers to purified product. 
1-[Alkyl(aryl)]-5-(3,3,3-trifluoro[chloro]-2-oxopropylidene)pyrrolidin-2-ones (5, 6)
To a stirred solution of appropriate methyl 7,7,7-trihalo-4-alkyl(aryl)amino-6-oxo-3-heptenoate (3 or 4, 2 mmol) in MeCN (5 mL), kept at 25 °C, was added Et 3 N (2 mmol, 0.3 mL) in MeCN (1 mL). The mixture was refluxed for 1 to 24 h and the solvent was removed under reduced pressure. The residue was crystallised from hexane, yield refers to purified product. 
Supplementary Information
Supplementary data shown in Tables S1 and S2 , using TMS as internal reference. Figure S3 . 1 H NMR spectrum from methyl 6-oxo-4-(2-phenylethyl)amino-7,7,7-trifluoro-4-heptenoate (3c), 400.13 MHz in CDCl 3 using TMS as internal standard. Figure S4 . 13 C{H} NMR spectrum from methyl 6-oxo-4-(2-phenylethyl)amino-7,7,7-trifluoro-4-heptenoate (3c), 100.62 MHz in CDCl 3 using TMS as internal standard .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51 Figurae S7. 1 H NMR spectrum from methyl 4-(4-methylphenyl)amino-6-oxo-7,7,7-trifluor-4-heptenoate (3e), 400.13 MHz in CDCl 3 using TMS as internal standard. Figure S8 . 13 C {H} NMR spectrum from methyl 4-(4-methylphenyl)amino-6-oxo-7,7,7-trifluor-4-heptenoate (3e), 100.62 MHz in CDCl 3 using TMS as internal standard .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 50 51 Figure S11 .
1 H NMR spectrum from methyl 4-(4-chlorophenyl)amino-6-oxo-7,7,7-trifluoro-4-heptenoate (3g), 400.13 MHz in CDCl 3 using TMS as internal standard. Figure S12 . 13 C {H} NMR spectrum from methyl 4-(4-chlorophenyl)amino-6-oxo-7,7,7-trifluoro-4-heptenoate (3g), 100.62 MHz in CDCl 3 using TMS as internal standard .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 50 51 Figure S15 .
1 H NMR spectrum from methyl 4-(4-aminophenyl)amino-6-oxo-7,7,7-trifluoro-4-heptenoate (3k), 400.13 MHz in CDCl 3 using TMS as internal standard.
Figure S16. 13 C {H} spectrum from methyl 4-(4-aminophenyl)-6-oxo-7,7,7-trifluoro-4-heptenoate (3k), 100.62 MHz in CDCl 3 using TMS as internal standard .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 50 51 Figure S19 .
1 H NMR spectrum from methyl 4-(5-methyl-3-isoxazolyl)amino-6-oxo-7,7,7-trifluoro-4-heptenoate (3i), 400.13 MHz in CDCl 3 using TMS as internal standard. Figure S20 . 13 C {H} NMR spectrum from methyl 4-(5-methyl-3-isoxazolyl)amino-6-oxo-7,7,7-trifluoro-4-heptenoate (3i), 100.62 MHz in CDCl 3 using TMS as internal standard .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 50 51 Figure S23 .
1 H NMR spectrum from 1-(2-phenylethyl)-5-(3,3,3-trifluoro-2-oxopropylidene)pyrrolidin-2-one (5c), 400.13 MHz in CDCl 3 using TMS as internal standard. Figure S24 . 13 C{H} NMR spectrum from 1-(2-phenylethyl)-5-(3,3,3-trifluoropro-2-oxopylidene)pyrrolidin-2-one (5c), 100.62 MHz in CDCl 3 using TMS as internal standard .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51 
